ArticleNeuropsychopharmacology reports2026
Catatonia an Unexpected Side Effect of Electroconvulsive Therapy: A Case Report.
Article in Neuropsychopharmacology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
introductionCatatonia is a neuropsychiatric syndrome characterized by motor and behavioral abnormalities, often associated with severe psychiatric or medical conditions. The use of electroconvulsive therapy (ECT) is a well-established treatment for catatonia; however, paradoxical onset during treatment is rare. CASE PRESENTATION: A 33-year-old woman with schizoaffective disorder, previously managed with antipsychotics, developed acute catatonia following the first ECT session. Her history included childhood epilepsy controlled with sodium valproate and long-term use of various antipsychotics, including clozapine. The patient developed stupor, mutism, and fixed staring immediately after ECT. All psychotropic medications were discontinued, and further ECT sessions were halted. The catatonia resolved within 24 h without further intervention. ECT was restarted after 7 days, leading to full remission after 15 sessions. DISCUSSION: This case underscores the hypothesis of a rare paradoxical occurrence of catatonia induced by ECT, despite the absence of classic predisposing factors. The timing of catatonia suggests a potential interaction between ECT and other medications, particularly haloperidol, and the tapering of clozapine. This phenomenon warrants further investigation into the neurochemical mechanisms that might contribute to ECT-induced catatonia.
conclusionThe occurrence of catatonia following ECT in this case underscores the need for careful monitoring, particularly in patients with complex psychiatric histories or any risk factor for catatonia. Although this phenomenon is rare, clinicians should be aware of the potential for catatonia to develop even in the absence of typical risk factors and take steps to manage it promptly.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.